Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
58.84
+0.47 (0.81%)
Dec 5, 2024, 4:00 PM EST - Market closed
BMY Revenue
Bristol-Myers Squibb Company had revenue of $11.89B in the quarter ending September 30, 2024, with 8.44% growth. This brings the company's revenue in the last twelve months to $47.44B, up 5.56% year-over-year. In the year 2023, Bristol-Myers Squibb Company had annual revenue of $45.01B, down -2.50%.
Revenue (ttm)
$47.44B
Revenue Growth
+5.56%
P/S Ratio
2.51
Revenue / Employee
$1,391,056
Employees
34,100
Market Cap
119.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 45.01B | -1.15B | -2.50% |
Dec 31, 2022 | 46.16B | -226.00M | -0.49% |
Dec 31, 2021 | 46.39B | 3.87B | 9.09% |
Dec 31, 2020 | 42.52B | 16.37B | 62.62% |
Dec 31, 2019 | 26.15B | 3.58B | 15.89% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Cigna Group | 229.75B |
Elevance Health | 174.02B |
Pfizer | 59.38B |
Sanofi | 54.03B |
Medtronic | 33.00B |
Amgen | 32.53B |
Gilead Sciences | 28.30B |
Stryker | 21.97B |
BMY News
- 2 days ago - Bristol-Myers Squibb Company (BMY) Citi's 2024 Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 days ago - AI Proteins Announces Research Collaboration and Option Agreement with Bristol Myers Squibb for Miniprotein-Based Therapeutics Valued up to $400M - Business Wire
- 2 days ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields - Benzinga
- 8 days ago - BMY Stock vs. JNJ Stock - Forbes
- 9 days ago - Bristol Myers Squibb to Participate in Citi's 2024 Global Healthcare Conference - Business Wire
- 9 days ago - Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies - Seeking Alpha
- 10 days ago - 5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade) - Seeking Alpha
- 12 days ago - Potential $5,000 Monthly Income: 10 Investments To Buy And Hold For Next 10 Years - Seeking Alpha